IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $572,000 | -5.5% | 13,725 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $605,000 | -50.4% | 13,725 | -43.3% | 0.02% | -48.3% |
| Q4 2017 | $1,219,000 | -2.8% | 24,225 | -2.0% | 0.03% | -6.5% |
| Q3 2017 | $1,254,000 | -4.0% | 24,725 | -3.7% | 0.03% | -3.1% |
| Q2 2017 | $1,306,000 | +24.4% | 25,675 | -1.7% | 0.03% | +23.1% |
| Q1 2017 | $1,050,000 | -27.1% | 26,125 | -13.3% | 0.03% | -31.6% |
| Q4 2016 | $1,441,000 | +30.5% | 30,125 | 0.0% | 0.04% | +31.0% |
| Q3 2016 | $1,104,000 | +57.3% | 30,125 | 0.0% | 0.03% | +52.6% |
| Q2 2016 | $702,000 | -55.1% | 30,125 | -22.0% | 0.02% | -34.5% |
| Q1 2016 | $1,564,000 | -35.5% | 38,625 | -1.3% | 0.03% | -35.6% |
| Q4 2015 | $2,423,000 | – | 39,125 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |